Viva Biotech Holdings (HKSE:01873) Gross-Profit-to-Asset % : 9.75% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Viva Biotech Holdings Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Viva Biotech Holdings's annualized Gross Profit for the quarter that ended in Dec. 2024 was HK$744 Mil. Viva Biotech Holdings's average Total Assets over the quarter that ended in Dec. 2024 was HK$7,629 Mil. Therefore, Viva Biotech Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 9.75%.

Viva Biotech Holdings Gross-Profit-to-Asset % Historical Data

The historical data trend for Viva Biotech Holdings's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viva Biotech Holdings Gross-Profit-to-Asset % Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

6.14

8.17

9.74

9.51

9.36

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial											11.43	10.00	8.53	9.20	9.75

Competitive Comparison of Viva Biotech Holdings's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Viva Biotech Holdings's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Viva Biotech Holdings's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Viva Biotech Holdings's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Viva Biotech Holdings's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Viva Biotech Holdings Gross-Profit-to-Asset % Calculation

Viva Biotech Holdings's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2024 )	/	( (Total Assets (A: Dec. 2023 )	+	Total Assets (A: Dec. 2024 ))	/ count )
	=	733.917	/	( (8148.556	+	7527.722)	/ 2 )
	=	733.917	/	7838.139
	=	9.36 %

Viva Biotech Holdings's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	743.642	/	( (7729.692	+	7527.722)	/ 2 )
	=	743.642	/	7628.707
	=	9.75 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Viva Biotech Holdings Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Viva Biotech Holdings's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Viva Biotech Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Viva Biotech Holdings (HKSE:01873) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

VBIZF:USA VB0:Germany

Address

735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website

https://www.vivabiotech.com

Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.

Executives

Mao Chen Cheney	2101 Beneficial owner
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
Mao Jun	2501 Other
Wu John Jiong	2201 Interest of corporation controlled by you
Fenghe Harvest Ltd	2101 Beneficial owner
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Zhou Min	2202 Interest of your spouse
Intertrust (singapore) Ltd.	2301 Trustee
Z&m International Holdings Limited	2201 Interest of corporation controlled by you
Zhang And Sons Limited	2101 Beneficial owner

Viva Biotech Holdings Headlines

No Headlines